TX-MAVENIR
29.5.2024 15:01:32 CEST | Business Wire | Press release
Mavenir, the cloud-native network infrastructure provider building the future of networks, today announces that its world-leading SpamShield messaging fraud prevention technology is driving a steep decline in the volume of spam and scam messages for Globe Telecom, Inc. in the Philippines – demonstrating its ability to disincentivize scammers and successfully boost customer protection against fraudulent, malicious and nuisance messaging. The Philippines is one of the large SMS markets in the world, and addressing the aggressive growth in the volume of spam and scam messaging is a key priority for the government’s National Telecommunications Commission (NTC).
In an impressive year-on-year improvement, Mavenir’s SpamShield has enabled the Philippines’ largest mobile operator to achieve a record 67% drop in blocked spam and scam SMS, plus a 74% decline in bank-related spam and scam messages during the first quarter of 2024, compared with the same period in 2023. The total number of blocked spam and scam SMS messages fell substantially from 1.1 billion in Q1 2023 to 362.8 million in Q1 2024. Over the same time span, the number of scam SMS messages directly reported by customers declined 44% year-on-year – from 610 in Q1 2023 to 342 in Q1 2024. Mavenir’s SpamShield technology has delivered an immediate and measurable impact for Globe – which reported blocking over 5 billion spam and scam messages in 2023 – by significantly raising the technical barriers to send fraudulent campaigns, increasing the cost of fraud, and removing profit incentives for scammers.
Mavenir’s SpamShield operates as a powerful SMS firewall – incorporating advanced monitoring, adaptive analytics, and real-time machine learning (ML) capabilities – that empowers Communication Service Providers (CSPs) to automatically block millions of fraudulent messages before they ever reach subscribers. SpamShield’s AI/ML detection algorithms adapt to current network conditions and subscriber behavior to continually detect spammer and fraudster attempts – enabling CSPs to quickly identify and act on potential threats and harmful events. This unique and innovative solution delivers an improved experience and greater security for customers, while protecting CSPs’ revenues from the negative costs of malicious activity.
Commenting on its successful spam reduction initiative, Anton Bonifacio, Chief Information Security Officer for Globe said: “Mavenir’s SpamShield technology has proven its ability to offer timely, precise, and effective threat detection and response, playing a central role in this dramatic reduction of spam and scam SMS traffic across our network to the immense benefit of all our customers. We now consider SpamShield an essential component of Globe’s anti-spam strategy moving forward, as we increase our innovation investment and strengthen our defenses against the tide of increasingly sophisticated fraudulent activity.”
Ilia Abramov, VP & GM of the Security Business Unit at Mavenir added: “Globe’s implementation of our SpamShield technology underlines its stringent and highly proactive approach to safeguarding customers, protecting users through the most robust and intelligent anti-spam messaging solution available today. The massive drop in blocked messages evidenced by these remarkable numbers shows how SpamShield achieves its transformative results in operation – making fraudulent activity prohibitively difficult and unprofitable for scammers, who then move on to easier and less protected targets including other operators and OTT channels such as WhatsApp. Globe is at the forefront of industry efforts to protect subscribers from this growing and ever-evolving array of threats, and we will continue to vigorously support its efforts to optimize communication safety and messaging authenticity in the Philippines.”
Notes to editors:
- Combating Messaging Scam and Fraud: A Telecom TV panel session with Globe recorded at MWC24: https://www.mavenir.com/resources/combating-messaging-scam-and-fraud/
About Globe:
Globe Telecom, Inc. is a leading full-service telecommunications company in the Philippines and publicly listed in the PSE with the stock symbol GLO. The company serves the telecommunications and technology needs of consumers and businesses across an entire suite of products and services including mobile, fixed, broadband, data connectivity, internet and managed services. It offers innovative digital solutions in the areas of fintech, healthtech, adtech, climatetech, shared services and venture capital. In 2019, Globe became a signatory to the United Nations Global Compact, committing to implement universal sustainability principles. Its principals are Ayala Corporation and Singtel, acknowledged industry leaders in the country and in the region.
About Mavenir:
Mavenir is building the future of networks today with cloud-native, AI-enabled solutions which are green by design, empowering operators to realize the benefits of 5G and achieve intelligent, automated, programmable networks. As the pioneer of Open RAN and a proven industry disruptor, Mavenir’s award-winning solutions are delivering automation and monetization across mobile networks globally, accelerating software network transformation for 300+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers. For more information, please visit www.mavenir.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240529690737/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CorFlow Therapeutics Announces Successful Completion of Phase 1 and First Patients Enrolled in Phase 2 of the MOCA II Pivotal Trial, Approval to Start the REVITALISE RCT in Europe, and Strengthening of Clinical Leadership30.4.2026 13:00:00 CEST | Press release
Milestones advance clinical progress and path to commercialization CorFlow Therapeutics AG (CorFlow), a clinical-stage company focused on transforming the diagnosis and treatment for heart attack patients, today announced multiple milestones in advancing its clinical program and the strengthening of clinical leadership. Phase 1 of the company’s MOCA II FDA Pivotal Trial was successfully reached after safety and performance goals were met with STEMI heart attack patients who had the proprietary PCoFI diagnostic measurement of microvascular obstruction (MVO) made during a stenting procedure, when compared to the reference standard diagnosis by cardiac MRI in the subsequent days. Phase 1 included 19 patients enrolled across 5 US and 3 European sites. MOCA II follows the FIH MOCA I study and primarily aims to validate the threshold value of the proprietary PCoFI measurement for diagnosing MVO in the setting of primary angioplasty compared to cardiac MRI. This milestone achievement, which w
Agendia to Present New Data Demonstrating the Expanded Clinical Utility of MammaPrint® and BluePrint® at the 2026 ESMO Breast Cancer Annual Congress30.4.2026 13:00:00 CEST | Press release
Poster presentations highlight the prognostic value of MammaPrint + Blueprint in small, node-negative tumors and impact of BMI on recurrence dynamics Agendia®, Inc., a leader in precision oncology for breast cancer, today announced it will present new data at the 2026 European Society for Medical Oncology (ESMO) Annual Congress on Breast Cancer, taking place May 6-8 in Berlin, Germany. The company will present two posters featuring data from the prospective FLEX Study and an independent post hoc analysis of the landmark MINDACT trial that underscore the prognostic value of MammaPrint® + BluePrint® in early-stage breast cancer (EBC). Poster #65P | Thursday, May 7, 13:15 – 14:15 p.m. CEST | Presenter: Elena Shagisultanova Prognostic Performance of MammaPrint in Patients with Small T1a, b, and c Node-Negative Early Breast Cancer A retrospective analysis from the FLEX Study involving 4,349 patients highlights the biological heterogeneity within small, node-negative (T1a, b, and c) tumors –
The Biggest Predictor of Business Growth Is Behavior30.4.2026 09:00:00 CEST | Press release
New IDEO research reveals a gap in the behaviors that most drive growth: long-term vision, rapid experimentation, and team autonomy—with only 10% of leaders saying their company excels at the combination. IDEO, the global design and innovation company, today announced the IDEO Innovation Quotient (IDEO IQ), a new report measuring how workplace behaviors drive business performance across 100 of the world’s largest companies. Those with the highest IDEO IQ scores earned nearly $20 billion in profit last year—50% higher than average and three times more than those ranked at the bottom. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429978890/en/ The IDEO Innovation Quotient (IDEO IQ) is a new report measuring how workplace behaviors drive business performance across 100 of the world’s largest companies. The IDEO IQ surveyed 266 leaders in product and innovation roles at 100 of the world’s largest companies across the Media &
Suzano Sells 12.7 Million Tonnes of Pulp for the First Time in Its History30.4.2026 00:22:00 CEST | Press release
Suzano(B3: SUZB3 | NYSE: SUZ), the world’s largest pulp producer, announces its results for the first quarter of 2026 (1Q26), achieving a new all‑time record in pulp sales. Over the 12‑month period from April 2025 to March 2026, the company sold 12.7 million tonnes of pulp, the highest volume ever recorded in its history. During the same period, Suzano also sold 1.7 million tonnes of paper across the packaging, printing and writing, specialty, and tissue segments. This unprecedented sales level mainly reflects the increase in production capacity following the start‑up of the Ribas do Rio Pardo pulp mill in the state of Mato Grosso do Sul, as well as Suzano’s strong operational efficiency across its production lines and supply chains, serving customers in more than 100 countries worldwide. In the first quarter of 2026, Suzano sold a total of 3.2 million tonnes, comprising 2.8 million tonnes of pulp and 378 thousand tonnes of paper. Net revenue amounted to BRL 11.0 billion, while adjuste
The Estée Lauder Companies Announces Minority Investment in Luxury Clinical Skin Care Brand 111SKIN29.4.2026 22:30:00 CEST | Press release
Surgeon-Founded Brand Anchored by Innovative NAC Y2™ Technology The Estée Lauder Companies Inc. (NYSE:EL) today announced a minority investment in 111SKIN, a luxury clinical skin care brand founded by renowned plastic and reconstructive surgeon Dr. Yannis Alexandrides. Terms of the investment were not disclosed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429495879/en/ 111SKIN's Reparative Collection Founded in 2012, 111SKIN was originally developed by Dr. Alexandrides to accelerate his patients’ healing time following procedures. At the heart of the brand is its innovative NAC Y2™, a pioneering complex designed to support skin repair and maintain a healthy, radiant and resilient complexion. Building on the foundation of this clinical expertise, 111SKIN has developed a portfolio of more than 30 products, anchored by its Black Diamond and Reparative collections and priced from $50 to $1,000. “Skin care is entering a new
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
